AI Stock Memo: COCO - Vita Coco - RankAlpha

COCO

Rating neutralAI Memo

Vita Coco

As of 2026-04-15/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-04-15 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

6‑12m

Key catalyst

Board retirement looks contained rather than thesis-changing • 2026-06-03

Expected move: -28%

Biggest risk

Conviction is capped by concentration and forward-proof issues: coconut water is still 96% of revenue, two customers represented 44% of 2025 sales, three suppliers represented 41% of purchases, and management's 2026 bridge depends on lower tariffs, pricing discipline, and private-label wins that are not yet demonstrated in 2026 reported results [#10-K-2026-02-18].

Invalidation

Break below $41 or thesis failure.

What would change my mind?

COCO has real operating quality: 2025 sales grew 18% to $610 million, adjusted EBITDA rose to $98 million, cash reached about $197 million, debt was zero, and management is guiding to another year of double-digit growth with better margins if tariffs ease and private label recovers [#PR-2026-02-18].

Research note

Recommendation

neutral

Confidence

medium

As of

2026-04-15

Base target

$53

p=47%

Bull target

$61

p=23%

Bear target

$41

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Board retirement looks contained rather than thesis-changing
2026 guide is the main rerating lever, but execution still has to be proven
Supply-chain durability is real, but concentration risk caps conviction

BearKey bullets

Customer concentration remains high, with two customers representing 44% of 2025 sales [#10-K-2026-02-18].
Private-label recovery from new and regained business disappoints versus guidance.
Supplier and packaging concentration constrain flexibility if sourcing or logistics hiccups emerge.

WatchKey bullets

At about $3.05 billion market cap, COCO trades near 5.0x trailing sales and roughly 4.4x FY2026 sales at the guidance midpoint; adjusting for about $197 million of cash and no debt implies roughly 23x forward EBITDA at the midpoint, which looks full for a medium-coverage consumer name given only moderate evidence quality, limited forward confirmation, and a negative short-horizon prior.

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $53 (p=47%)

Bull/Bear spread: -17% / -44%

Vs latest close: Bull -17% · Base -28% · Bear -44%

Scenario probabilities

Bull Target: $61 (p=23%)Base Target: $53 (p=47%)Bear Target: $41 (p=30%)

Commentary

This should remain a tentative monitoring memo, not a standard-conviction call. Primary-source evidence is solid, but recent news flow is sparse, peer fit is loose, and the deterministic prior is negative across 5d/20d/60d/120d horizons with only mid-level evidence quality (0.54) and catalyst density (0.50), while forward proof for the 2026 bridge is still limited.

As of 2026-04-15 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Board retirement looks contained rather than thesis-changing
2026 guide is the main rerating lever, but execution still has to be proven
Supply-chain durability is real, but concentration risk caps conviction

Scenarios

Bull Target (Scenario probability)

$61 / p=23% prob

Base Target (Scenario probability)

$53 / p=47% prob

Bear Target (Scenario probability)

$41 / p=30% prob

Price $73 as of 2026-07-16

Nearest Scenario: Bull (∆ 17%)

Targets vs latest close: Bull -17% · Base -28% · Bear -44%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Short-term Catalysts

Next few weeks

Board retirement looks contained rather than thesis-changing
2026-06-03
John Leahy said he will not stand for reelection at the June 3, 2026 annual meeting, and the company said the decision was for personal reasons with no disagreement on operations, policies, or practices, which suggests limited near-term operating impact despite a minor governance overhang [#8-K-2026-04-10].
Prob 75% • Move 2% • Priced-in 85%

Long-term Catalysts

Months to a year

2026 guide is the main rerating lever, but execution still has to be proven
2026-12-31
The February 18, 2026 earnings release guided to 2026 net sales of $680-$700 million, gross margin of about 38%, and adjusted EBITDA of $122-$128 million after 2025 net sales rose to $610 million and adjusted EBITDA to $98 million; with no 2026 reported quarter yet in the packet, this remains a monitoring setup that needs multiple quarterly checkpoints to confirm the tariff, pricing, and private-label bridge [#PR-2026-02-18].
Prob 50% • Move 10% • Priced-in 45%
Supply-chain durability is real, but concentration risk caps conviction
2026-12-31
Vita Coco extended its Century Pacific manufacturing agreement to December 31, 2030 and described a six-country factory network, which supports capacity and sourcing flexibility, but the 10-K still shows coconut water at 96% of revenue, Customer A and Customer B at 19% and 25% of 2025 sales, and Suppliers A/B/C at 18%, 13%, and 10% of purchases, keeping execution risk elevated [#8-K-2025-06-12] [#10-K-2026-02-18].
Prob 58% • Move 8% • Priced-in 55%

Risks

Customer concentration remains high, with two customers representing 44% of 2025 sales [#10-K-2026-02-18].
Private-label recovery from new and regained business disappoints versus guidance.
Supplier and packaging concentration constrain flexibility if sourcing or logistics hiccups emerge.
Tariff changes or competitor pricing responses pressure the 2026 gross-margin bridge.
The current board transition is low impact on paper, but any further governance churn would matter more than this filing alone implies.

Peers

Symbol	Summary
FIZZ	National Beverage is the cleanest public beverage comp in the packet because it is also a branded, asset-light beverage company with strong cash generation, though its category mix is broader and less exposed to a single hydration niche than COCO.
CCU	CCU offers a beverage distribution and international-market comparator, but it is a much broader alcohol-and-soft-drink portfolio and is not a direct functional hydration peer, so its read-through is limited.
FRPT	Freshpet is a looser premium-growth consumer brand comp; it is useful mainly as a reminder that high-growth branded stories can hold premium multiples, but the category and margin structure are materially different from COCO.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-04-15